Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Researchers have developed a machine learning algorithm that could improve clinicians’ ability to identify hospitalised patients who need intensive care.

Hospital room with two beds © (Photo by Daan Stevens on Unsplash)

The HAVEN system was developed as part of a collaboration between the University of Oxford’s Institute of Biomedical Engineering and the Nuffield Department of Clinical Neurosciences (NDCN), with support from the NIHR Oxford Biomedical Research Centre.

The findings of the study have been published in the American Journal of Respiratory and Critical Care Medicine.

'The HAVEN machine learning algorithm, using electronic patient data collected routinely by most NHS hospitals, has the potential to substantially improve our ability to detect patients who require ICU, and those for whom a timely intervention is likely to change their outcome, so enhancing the National Early Warning Score (NEWS) system currently in use across the health service,' said Professor Peter Watkinson, Associate Professor of Intensive Care Medicine at NDCN.

The HAVEN (Hospital-wide Alerting Via Electronic Noticeboard) system combines patients’ vital signs - such as blood pressure, heart rate and temperature - with their blood test results, comorbidities and frailty into a single risk score. The HAVEN score gives a more precise indication of which patients are deteriorating when compared with previously published scores.

Every year, more than 60,000 patients deteriorate on UK hospital wards to the extent they require admission to an ICU.

Over the past 20 years, health care systems worldwide have implemented alerting systems to improve detection of patients at risk of deterioration. Most are based on abnormalities in patients’ vital signs, usually by combining them into an early warning score. Clinicians are alerted when the EWS rises above a given threshold.

'Late recognition of patient deterioration in hospital is associated with worse outcomes, including higher mortality. Despite the widespread introduction of early warning score systems, which are based on vital signs, deterioration still goes unrecognised,' Professor Watkinson explained.

'The HAVEN system we have developed and validated was able to detect nearly twice as many patients who suffered a cardiac arrest or needed intensive care up to 48 hours in advance, than the next best system.'

As well as the Oxford BRC, this independent research was funded by the Health Innovation Challenge Fund, a funding partnership between the Department of Health and Wellcome Trust.

Similar stories

NICE recommends offering app-based treatment for people with insomnia instead of sleeping pills

Hundreds of thousands of people suffering from insomnia who would usually be prescribed sleeping pills could be offered an app-based treatment programme instead, NICE has said.

Developmental dynamics of the neural crest–mesenchymal axis in creating the thymic microenvironment

A new paper from researchers at the Department of Paediatrics and the Nuffield Department of Clinical Neurosciences has shown that fibroblasts in the thymus, often considered simply as dull “structural” cells, are much more complex than previously thought.

How to use the science of the body clock to improve our sleep and health

Professor Russell Foster has written a new book about circadian neuroscience which is published by Penguin this week. This book review by Jacqueline Pumphrey was first published on the University of Oxford website.

Funding awarded for autoimmune disease research

Dr Kate Attfield awarded project funding by Connect Immune Research and The Lorna and Yuti Chernajovsky Biomedical Research Foundation.

Oxford researchers part of major UK initiative to understand chronic pain

Oxford pain researchers are playing a major role in a new multi-million pound research programme launched by a consortium of funders, including UKRI, Versus Arthritis, Eli Lilly and the Medical Research Foundation.